Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen

When Pfizer and BioNTech struck a massive deal to supply Europe with up to 1.8 billion doses of their COVID-19 vaccine, government officials lauded the deal. But now that vaccine demand has cratered and governments have too many doses, many officials are singing a different tune.